Inhibition of human CYP1A2 activity in vitro by methylxanthines: potent competitive inhibition by 8-phenyltheophylline

References

• ADAMS, D. A., MURRAY, S., CLIFFORD, C. P., RENDELL, N. B., DAvrEs, D. S. and TAYLOR, G. W., 1997, Analysis of terfenadine in human plasma using microbore high-performance liquid chromatography- electrospray ionisation mass spectrometry. Journal of Chromatography B, 693, 345–351.
   PubMed Web of Science ®Google Scholar
• ALVARES, A. P., SCHILLING, G., GARBUT, A. and KuNTzmAN, R., 1970, Studies on the hydroxylation of 3,4-benzpyrene by hepatic microsomes: effect of albumin on the rate of hydroxylation of 3,4-benzpyrene. Biochemical Pharmacology, 19, 1449–1455.
   PubMed Web of Science ®Google Scholar
• BALL, S. E., FORRESTER, L. M., WOLF, C. R. and BACK, D. J., 1990, Differences in the cytochrome P450 isoenzymes involved in the 2-hydroxylation of oestradiol and 17a-ethynyloestradiol. Relative activities of rat and human liver enzymes. Biochemical Journal, 267, 221–226.
   PubMed Web of Science ®Google Scholar
• BOOB'S, A. R., 1995, Prediction of inhibitory drug-drug interactions by studies in vitro. In G. M. Pacifici and G. N. Fracchia (eds), Advances in Drug Metabolism in Man (Luxembourg: Office for Official Publications of the European Communities), pp. 513–539.
   Google Scholar
• BOOB'S, A. R., KAHN, G. C., WHYTE, C., BRODIE, M. J. and DAvrEs, D. S., 1981, Biphasic O-deethylation of phenacetin and 7-ethoxycoumarin by human and rat liver microsomal fractions. Biochemical Pharmacology, 30, 2451–2456.
   Google Scholar
• BOOB'S, A. R., LYNCH, A. M., MURRAY, S., DE LA TORRE, R., SOLANS, A., FARRE, M., SEGURA, J., GOODERHAM, N. J. and DAVIES, D. S., 1994, CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans. Cancer Research, 54, 89–94.
   Google Scholar
• BOOB'S, A. R., MURRAY, S., KAHN, G. C., ROBERTZ, G.-M. and DAvrEs, D. S., 1983, Substrate specificity of the form of cytochrome P-450 catalysing the 4-hydroxylation of debrisoquine in man. Molecular Pharmacology, 23, 474–481.
   Google Scholar
• BOOBIS, A. R., SESARDIC, D. and GOODERHAM, N. J., 1990, Methods in drug metabolism. In C. Hansch, P. G. Samrnes and J. B. Taylor (eds), Comprehensive Medicinal Chemistry, vol. 5: Biopharmaceutics (Oxford: Pergamon), pp. 443–478.
   Google Scholar
• BUTLER, M. A., IwAsmu, M., GUENGERICH, F. P. and KADLUBAR, F. F., 1989, Human cytochrome P-450pA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proceedings of the National Academy of Sciences, USA, 86, 7696–7700.
   PubMed Web of Science ®Google Scholar
• CHAURET, N., GAUTHIER, A. and NICOLL-GRIFFITH, D. A., 1998, Effect of common organic solvents on in vitro cytochrome P450 mediated metabolic activities in human liver microsomes. Drug Metabolism and Disposition, 26, 1–4.
   PubMed Web of Science ®Google Scholar
• CONNEY, A. H., PANTUCK, E. J., HSIAO, K.-C., GARLAND, W. A., ANDERSON, K. E., ALVARES, A. P. and KAPPAS, A., 1976, Enhanced phenacetin metabolism in human subjects fed charcoal-broiled beef. Clinical Pharmacology and Therapeutics, 20, 633–642.
   Google Scholar
• Duaz, D., FABRE, I., DAUJAT, M., SAINT-AUBERT, B., BORIES, P., MICHEL, H. and MAUREL, P., 1990, Omeprazole is an aryl hydrocarbon like inducer of human hepatic cytochrome P450. Gastroenterology, 99, 737–747.
   Google Scholar
• DOLLERY, C., 1991, Caffeine, oxpentifylline and theophylline. In Therapeutic Drugs (Edinburgh: Churchill Livingstone), pp. C3-C6, O50-053, T32-T41 respectively.
   Google Scholar
• EDWARDS, R. J., MURRAY, B. P., SINGLETON, A. M. and BOOBIS, A. R., 1991, Orientation of cytochromes P450 in the endoplasmic reticulum. Biochemistry, 30, 71–76.
   PubMed Web of Science ®Google Scholar
• ELLISON, M. J., HORNER, R. D., WILLIS, S. E. and CUMMINGS, D. M., 1990, Influence of pentoxifylline on steady-state theophylline serum concentrations from sustained-release formulations. Pharmacotherapy, 10, 383–386.
   PubMed Web of Science ®Google Scholar
• FUHR, U., DOEHMER, J., BATTULA, N., WOLFEL, C., KUDLA, C., KEttA, Y. and STAIB, A. H., 1992, Biotransformation of caffeine and theophylline in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms. Biochemical Pharmacology, 43, 225–235.
   PubMed Web of Science ®Google Scholar
• GILLAM, E. M. and REILLY, P. E., 1988, Phenacetin O-deethylation by human liver microsomes: kinetics and propranolol inhibition. Xenobiotica, 18, 95–104.
   PubMed Web of Science ®Google Scholar
• KIMURA, S., UMENO, M., SKODA, R. C., MEYER, U. A. and GONZALEZ, F. J., 1989, The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene. American Journal of Human Genetics, 45, 889–904.
   PubMed Web of Science ®Google Scholar
• KOBAYASHI, S., MURRAY, S., WATSON, D., SESARDIC, D., DAvrEs, D. S. and BOOBIS, A. R., 1989, The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man. Biochemical Pharmacology, 38, 2795–2799.
   PubMed Web of Science ®Google Scholar
• KUNZE, K. L. and TRAGER, W. F., 1993, Isoform-selective mechanism-based inhibition of human cytochrome P4501A2 by furafylline. Chemical Research in Toxicology, 6, 649–656.
   PubMed Web of Science ®Google Scholar
• MEESE, C. O., 1986, Synthesis of 1,1,3,3,-(2H4)-4-hydroxydebrisoquine sulphate. Journal of Labelled Compounds and Radiopharmaceuticals, 23, 427–432.
   Google Scholar
• MICHNOVICZ, J. J. and BRADLOW, H. L., 1990, Induction of estradiol metabolism by dietary indole-3-carbinol in humans. Journal of the National Cancer Institute, 82, 947–949.
   PubMed Web of Science ®Google Scholar
• MINERS, J. O., SMITH, K. J., ROBSON, R. A., McMANus, M. E., VERONESE, M. E. and BIRKETT, D. J., 1988, Tolbutamide hydroxylation by human liver microsomes. Kinetic characterisation and relationship to other cytochrome P450 dependent xenobiotic oxidations. Biochemical Pharmacology, 37, 1137–1144.
   PubMed Web of Science ®Google Scholar
• MURRAY, S. and BOOBIS, A. R., 1986, An assay for paracetamol, produced by the O-deethylation of phenacetin in vitro, using gas chromatography/electron capture negative-ion chemical ionization mass spectrometry. Biomedical and Environmental Mass Spectrometry, 13, 91–93.
   PubMedGoogle Scholar
• MURRAY, S. and WADDELL, K. A., 1982, The electron capture negative-ion chemical ionisation mass spectra of 2- (4', 6 '-bistrifluoromethyl-2' -pyrimidinyl)tetrahydroisoquinoline and 4-substituted analogues. Biomedical Mass Spectrometry, 9, 466–472.
   Google Scholar
• NEBERT, D. W. and GIELEN, J. E., 1972, Genetic regulation of aryl hydrocarbon hydroxylase induction in the mouse. Federation Proceedings, 31, 1315–1325.
   PubMedGoogle Scholar
• PETER, R., BOCKER, R., BEAUNE, P. H., IWASAKI, M., GUENGERICH, F. P. and YANG, C. S., 1990, Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-45011E1. Chemical Research in Toxicology, 3, 566–573.
   PubMed Web of Science ®Google Scholar
• PETERSON, T. C., 1996, Inhibition of fibroproliferation by pentoxifylline. Activity of metabolite-1 and lack of role of adenosine receptors. Biochemical Pharmacology, 52, 597–602.
   PubMed Web of Science ®Google Scholar
• RAUCY, J. L., LASKER, J. M., LIEBER, C. S. and BLACK, M., 1989, Acetaminophen activation by human liver cytochrome P45011E1 and P4501A2. Archives of Biochemistry and Biophysics, 271, 270–283.
   PubMed Web of Science ®Google Scholar
• RODRIGUES, A. D., SURBER, B. W., YAO, Y., WONG, S. L. and ROBERTS, E. M., 1997, [0-ethyl 14C]phenacetin O-deethylase activity in human liver microsomes. Drug Metabolism and Disposition, 25, 1097–1100.
   PubMed Web of Science ®Google Scholar
• SANZ, F., LOPEZ-DE-BRINAS, E., RODRIGUEZ, J. and MANAUT, F., 1994, Theoretical study on the metabolism of caffeine by cytochrome P4501A2 and its inhibition. Quantitative Structure-Activity Relationships, 13, 281–284.
   Google Scholar
• SEGURA, J., ROBERTS, D. J. and TARRUS, E., 1989, The influence of structure on the accumulation of caffeine induced by methyl xanthine derivatives. Journal of Pharmacy and Pharmacology, 41, 129–131.
   PubMed Web of Science ®Google Scholar
• SESARDIC, D., BOOBIS, A. R., EDWARDS, R. J. and DAvrEs, D. S., 1988, A form of cytochrome P450 in man, orthologous to form din the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking. British Journal of Clinical Pharmacology, 26, 363–372.
   PubMed Web of Science ®Google Scholar
• SESARDIC, D., Booms, A. R., MURRAY, B. P., MURRAY, S., SEGURA, J., DE LA TORRE, R. and DAvrEE, D. S., 1990a, Furafylline is a potent and selective inhibitor of cytochrome P4501A2 in man. British Journal of Clinical Pharmacology, 29, 651–663.
   PubMed Web of Science ®Google Scholar
• SESARDIC, D., EDWARDS, R. J., DAvrEE, D. S., THOMAS, P. E., LEVIN, W. and Booms, A. R., 1990b, High affinity phenacetin O-deethylase is catalysed specifically by cytochrome P450d (P450IA2) in the liver in the rat. Biochemical Pharmacology, 39, 489–498.
   PubMed Web of Science ®Google Scholar
• VENKATAKRISHNAN, K., VON MOLTKE, L. L. and GREENBLATT, D. J., 1998, Human cytochromes P450 mediating phenacetin O-deethylation in vitro: validation of the high affinity component as an index of CYP1A2 activity. Journal of Pharmaceutical Sciences, 87, 1502–1507.
   PubMed Web of Science ®Google Scholar
• VERONESE, M. E., DOECKE, C. J., MACKENZIE, P. I., McMANus, M. E., MINERS, J. O., REES, D. L., GASSER, R., MEYER, U. A. and BIRKETT, D. J., 1993, Site-directed mutation studies of human liver cytochrome P-450 isoenzymes in the CYP2C subfamily. Biochemical Journal, 289, 533–538.
   PubMed Web of Science ®Google Scholar
• YUN, C.-H., OKERHOLM, R. A. and GUENGERICH, F. P., 1993, Oxidation of the antihistamine drug terfenadine in human liver microsomes. Role of cytochrome P450 3A(4) in N-dealltylation and C-hydroxylation. Drug Metabolism and Disposition, 21, 403–409.
   PubMed Web of Science ®Google Scholar